Calithera Biosciences, Inc. (CALA)

USD 0.0

(0.0%)

Annual Income Statements

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Revenue - 9.75 Million - - 22.25 Million 25.95 Million
Cost of Revenue 1.38 Million 1.43 Million 1.87 Million 1.84 Million - -
Gross Profit -1.38 Million 8.31 Million -1.87 Million -1.84 Million 22.25 Million 25.95 Million
Operating Expenses 40.68 Million 74.3 Million 91.38 Million 92.89 Million 79.53 Million 55.64 Million
Selling, General and Administrative Expenses 12.15 Million 20.85 Million 20.37 Million 16.6 Million 13.34 Million 12.53 Million
Research and Development Expenses 28.53 Million 53.45 Million 71.01 Million 76.29 Million 66.19 Million 43.11 Million
Other Expenses - 50.87 Million - - - -
Cost and Expenses 42.07 Million 74.3 Million 91.38 Million 92.89 Million 79.53 Million 55.64 Million
Operating Income -42.07 Million -115.43 Million -91.38 Million -92.89 Million -57.28 Million -29.68 Million
Interest Expense - - - - - -
Income Tax Expense -20.78 Million 50.25 Million -1.61 Million -3.51 Million -3.15 Million -365 Thousand
Earnings before Tax -39.65 Million -115.08 Million -90.13 Million -89.86 Million -54.62 Million -27.82 Million
Net Income -18.86 Million -165.33 Million -88.52 Million -86.34 Million -51.47 Million -27.82 Million
Earnings Per Share Basic -7.94 -44.77 -25.73 -36.50 -28.12 -16.89
Earnings Per Share Diluted -7.94 -44.77 -25.73 -36.50 -28.12 -16.89
Weighted Average Shares Outstanding 4.99 Million 3.69 Million 3.44 Million 2.36 Million 1.83 Million 1.64 Million
Weighted Average Shares Outstanding (Diluted) 4.99 Million 3.69 Million 3.44 Million 2.36 Million 1.83 Million 1.64 Million
Gross Margin - 0.85 - - 1.00 1.00
EBIT Margin - -1.40 - - -2.57 -1.14
Profit Margin - -16.96 - - -2.31 -1.07
EBITDA -38.26 Million -115.43 Million -88.26 Million -88.01 Million -57.28 Million -29.68 Million
Earnings Before Tax Margin - -11.84 - - -2.57 -1.14

Income Statement Charts